Anna Gill

Anna Gill joined the ALS Therapy Development Institute in 2015. She started as a part-time research intern while completing her Bachelor's degree, and transitioned to a full-time scientist on the In-vivo team starting in 2018. Her current focus is studying the biological mechanisms of C9ORF72-ALS pathology using newly-developed cell-based models and assays. Anna graduated cum laude from Emmanuel College with a B.S. in Biology concentrating in Health Sciences and intends to pursue a graduate degree. As a full-time student and part-time intern, she wrote and defended an undergraduate thesis titled "Investigating cellular effects of neurodegeneration-associated peptides in C9ORF72 ALS" based on research done at ALS-TDI. Her parents Alan and Cindy Gill have worked at ALS TDI for over 10 years, which gave her a unique opportunity to watch the institute grow from the ground up.